We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

All eyes on antitrust enforcement in China's pharmaceutical industry

July 2016

Competition Policy International (CPI) Antitrust Chronicle
A wide range of recent antitrust enforcement actions in the pharmaceutical sector have taken place in China over the past months.

All three Chinese antitrust authorities have been involved, and all types of anti-competitive conduct have been targeted. The multiple actions described above put the pharmaceutical sector very clearly into the spotlight. Very few other sectors have seen the same level of antitrust enforcement activism in recent months, and there does not seem to be an end in sight to this activism."

Read the full article here.

The team

Loading data